LIPELLA PHARMACEUTICALS INC.

Lipella Pharmaceuticals (LIPO) has recorded zero cyber incidents and zero red-flag 8-K filings over the past 90 days based on our real-time monitoring pipeline. However, low signal in our 90-day window does not mean low risk; the company's capital structure and financing history warrant deeper examination. The full $49 Report extends analysis to 12 months of SEC filings, adds a proprietary dilution risk score, contextualizes any 8-K events, and identifies AI-detected risk signals across the company's disclosure patterns. The full $49 Report adds comprehensive dilution analysis, 12-month event history, and machine-detected anomalies in regulatory filings.